Changes in the organisms of resistant peritonitis in patients on continuous ambulatory peritoneal dialysis
- PMID: 15384795
Changes in the organisms of resistant peritonitis in patients on continuous ambulatory peritoneal dialysis
Abstract
Peritonitis is one of the most serious complications of continuous ambulatory peritoneal dialysis (CAPD). Approximately 20% of peritonitis infections have been reported to be resistant to initial therapy, either failing to resolve with appropriate antibiotics or relapsing within 2 weeks of antibiotic discontinuation. To investigate the current situation with regard to resistant peritonitis, we retrospectively examined the incidence and the organisms of resistant peritonitis in our unit over a period of 9 years. From January 1, 1994, to January 1, 2003, we introduced 325 patients onto CAPD. At January 1, 2003, we followed up 172 patients who were receiving CAPD in our unit. During 1994-1996, 12 cases of peritonitis and 3 cases of resistant peritonitis (25%) occurred among our patients. Microbiologic examination revealed that the organisms involved in peritonitis were alpha-streptococcus (17%), coagulase-negative staphylococcus [CNS (17%)], and methicillin-sensitive Staphylococcus aureus [MSSA (17%)]. The organisms of resistant peritonitis were methicillin-resistant S. aureus [MRSA (67%)] and methicillin-resistant CNS (33%). During 1997-1999, 39 cases of peritonitis and 13 cases of resistant peritonitis (33%) occurred among our patients. The most frequently cultured organisms in peritonitis were CNS (26%), Candida species (13%), and alpha-streptococcus (10%). The organisms of resistant peritonitis were methicillin-resistant CNS (46%) and Candida species (38%). In the most recent 3-year period (2000-2002), our patients experienced 57 cases of peritonitis and 24 cases of resistant peritonitis (42%). The organisms of peritonitis were alpha-streptococcus (46%), CNS, MSSA, Escherichia coli, and Candida species (38%). However, the organisms of resistant peritonitis were methicillin-resistant CNS (13%), Candida species (21%), Pseudomonas aeruginosa (13%), Serratia (13%), Citrobacter (13%), and Corynebacterium (13%). In the last several years, methicillin-resistant CNS has come to be main organism of resistant peritonitis. In addition, opportunistic infection has become a serious peritonitis problem. Given these data, we conclude that the incidence of resistant peritonitis is increasing and that the organisms of resistant peritonitis are changing.
Similar articles
-
The effects of once- or thrice-weekly mupirocin application on mupirocin resistance in patients on continuous ambulatory peritoneal dialysis--first 6 months' experience.Adv Perit Dial. 2004;20:62-6. Adv Perit Dial. 2004. PMID: 15384797 Clinical Trial.
-
Effect of once-a-week vs thrice-a-week application of mupirocin on methicillin and mupirocin resistance in peritoneal dialysis patients: three years of experience.Ren Fail. 2008;30(4):417-22. doi: 10.1080/08860220801964228. Ren Fail. 2008. PMID: 18569916 Clinical Trial.
-
[Evaluation of the epidemiological, clinical and laboratory findings in continuous ambulatory peritoneal dialysis related peritonitis attacks].Mikrobiyol Bul. 2008 Apr;42(2):255-64. Mikrobiyol Bul. 2008. PMID: 18697423 Turkish.
-
[Microbiological diagnosis of peritonitis in patients undergoing continuous ambulatory peritoneal dialysis. Review of 5 years at the Hospital de Galdakao].Enferm Infecc Microbiol Clin. 1993 Apr;11(4):178-81. Enferm Infecc Microbiol Clin. 1993. PMID: 8512967 Review. Spanish.
-
[The latest trends in the treatment peritonitis of the patients on peritoneal dialysis].Vnitr Lek. 2004 Aug;50(8):619-23. Vnitr Lek. 2004. PMID: 15521206 Review. Czech.
Cited by
-
Coagulase negative staphylococcal peritonitis in peritoneal dialysis patients: review of 232 consecutive cases.Clin J Am Soc Nephrol. 2008 Jan;3(1):91-7. doi: 10.2215/CJN.03070707. Epub 2007 Nov 21. Clin J Am Soc Nephrol. 2008. PMID: 18032790 Free PMC article.
-
Verification and application of a modified carbapenem inactivation method (mCIM) on Pseudomonas aeruginosa: a potential screening methodology on carbapenemases phenotype in Bacillus cereus.Bioengineered. 2022 May;13(5):12088-12098. doi: 10.1080/21655979.2022.2072601. Bioengineered. 2022. PMID: 35577356 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical